Bausch Health to Announce First Quarter Results on April 30
-
In Ghana, larger-than-life coffins tell the stories of the dead
-
Rare trio of Pacific hurricanes fueled by historic El Nino
-
Menoncello, Reece headline Top 14 new-season signings
-
Chinese WNBA star out of World Cup after losing passport
-
Families descend on Nepal in search of missing tourists
-
Medieval Europe and Africa collide in Sao Tome traditional theatre
-
Far-right AfD eyes huge win in east German state vote
-
Iran attacks US targets despite Trump threats
-
Brazil-Japan to play World Cup rematch at Singapore tournament
-
Alcaraz believes 'impossible' schedule raising injury threat
-
Defence chiefs back boosting US military presence in Australia
-
Alcaraz rallies to reach US Open third round, Sabalenka storms through
-
Nepal seeks climate justice after Himalayan disaster
-
Alcaraz overpowers Faria to reach US Open third round
-
Stocks rise, yields ease as oil slips on Trump hint at short bombing campaign
-
Hamilton hopes to boost title bid with record Italian triumph
-
Brussels Diamond League finals Day 1 - five events to watch
-
Iran, US trade threats after fresh strikes
-
Thailand's 'Jurassic Park' shines light on dinosaur evolution
-
US not 'stealing Venezuelan oil,' energy secretary insists
-
'Role model' Stokes set to open for Adelaide Strikers
-
Farming experts tout 'conscious' food systems to fix agriculture woes
-
Palau urges 'unified' Pacific response to China missile test
-
George Lucas unveils art galaxy at his new LA museum
-
Grinding away: in remote Appalachia, old mills fuel US clean food dreams
-
Veteran Wallaby Slipper targets fifth World Cup after Brumbies deal
-
Sabalenka races into US Open third round
-
Sabalenka storms into US Open third round as Pegula, Medvedev advance
-
NSW's Fourth-Largest City Makes Its Move: Investing Platform Spotlights Wollongong's Health Precinct Plan and 20,500-Job Target
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 03
-
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
-
Costa Rica Makes History as First Latin American Country to Launch English Learning as a National Initiative with Open English
-
Chinese lucky loser stuns Jodar at US Open
-
Zverev looks to improve after first-round scare
-
US Open under the influence: content creators spark debate
-
Raiders to start Cousins over top NFL Draft pick Mendoza
-
NBA hammers Clippers over Leonard salary cap violations
-
Palantir chief says France's digital sovereignty push 'backfiring'
-
NBA strips five first-round draft picks from Clippers for Leonard salary cap violations
-
US energy firms dominate Venezuela deals worth billions
-
Kane brace helps Bayern win German Cup opener
-
Iran, US trade threats after escalation in fighting
-
Migrant plight, local anger divide Ceuta one month after influx
-
US jury deadlocks again in Lindsay Clancy's child murder trial
-
Outrage as Maltese tycoon acquitted of reporter's murder
-
Lake America? No way, Canadians say
-
Rare train of Pacific cyclones fueled by historic El Nino
-
Spain report flags Moroccan police failings in Ceuta migrant rush
-
Macron, King Charles hail UK-France ties after viewing Bayeux Tapestry
-
Tech bosses press G20 to build data centers, but split on risk
Bausch Health to Announce First Quarter Results on April 30
LAVAL, QC / ACCESS Newswire / March 27, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Wednesday, April 30, 2025 |
Time: | 5:00 p.m. U.S. EDT |
Webcast: |
A replay of the conference call will be available on the investor relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll-free) | (908) 541-3785 |
SOURCE: Bausch Health Companies Inc
View the original press release on ACCESS Newswire
W.Stewart--AT
